文献速递多重用药安宁疗护认知障碍与谵妄

美国痴呆症养老院居民临终前一年用药轨迹

Trajectories of Medication Use Prior to Death in US Nursing Home Residents With Dementia.
PubMed 文献 · J Am Med Dir Assoc · 2026-07-02

结果显示抗凝药、抗焦虑药和抗生素使用呈上升趋势,而抗抑郁药、利尿剂、抗精神病药和催眠药使用下降。功能与认知损害更重及临终关怀入组与生前至少停用一种药物相关。

要点

  • 痴呆症养老院居民临终前一年抗凝药、抗焦虑药和抗生素使用增加,抗抑郁药、利尿剂、抗精神病药和催眠药减少。
  • 功能损害更重(重度aOR 1.48,95%CI 1.39-1.58)与更高停药几率相关。
  • 临终关怀入组(痴呆aOR 1.22,95%CI 1.19-1.25;非痴呆aOR 1.29,95%CI 1.26-1.32)与更高停药几率相关。

核心结论

  • 痴呆症养老院居民临终前一年慢病药物如抗凝药使用增加,提示需进一步指导临终处方。

主要发现

  • 与临终前12个月相比,临终前最近一次MDS 3.0评估中抗凝药、抗焦虑药和抗生素使用增加,抗抑郁药、利尿剂、抗精神病药和催眠药使用减少,所有药物类别趋势显著。
  • 功能损害重度(aOR 1.48;95%CI 1.39-1.58)和中度(aOR 1.11;95%CI 1.04-1.18)与更高停药几率相关。
  • 认知损害重度(aOR 1.25;95%CI 1.23-1.28)和中度(aOR 1.08;95%CI 1.05-1.11)与更高停药几率相关。
  • 临终关怀入组(痴呆aOR 1.22;95%CI 1.19-1.25;非痴呆aOR 1.29;95%CI 1.26-1.32)与更高停药几率相关。

关键数值与推荐

  • 用药结局基于预设MDS 3.0清单,包括抗凝药、利尿剂、抗精神病药、抗焦虑药、抗抑郁药、催眠药和抗生素。
  • 采用卡方趋势检验分析用药轨迹,多变量逻辑模型识别与停药及启动相关的因素。

临床怎么用

  • 对痴呆症养老院居民临终前应关注抗凝药等慢病药物的使用合理性,结合功能与认知损害程度及临终关怀状态评估停药与启动决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Polypharmacy and questionably beneficial medication use are common among nursing home (NH) residents with dementia. Deprescribing patterns in this population are not well described. This study describes trajectories of medication use in NH residents with dementia in the year prior to death. DESIGN: Repeated cross-sectional analysis. SETTING AND PARTICIPANTS: US NH decedents with dementia. METHODS: Trajectories of medication use at 90-day intervals in the year before death using the 2014 to 2018 Minimum Data Set 3.0 (MDS 3.0). Outcomes are based on a prespecified MDS 3.0 checklist of medications, including select chronic disease medications (anticoagulants and diuretics), psychoactive medications (antipsychotics, anxiolytics, antidepressants, and sedative hypnotics), and antibiotics. Chi-square test of trend examined medication use trajectories. Multivariable logistic models identified factors associated with (1) overall deprescribing, (2) deprescribing, and (3) initiation of each medication class in the 3 months prior to death. RESULTS: A total of 1.12 million decedents with dementia were included in the study. Comparing medication use 12 months prior to death to medication use in the MDS 3.0 assessment closest to death, there were significant trends in medication use for all drug classes, including increases in anticoagulants, anxiolytics, and antibiotics, and decreases in antidepressants, diuretics, antipsychotics, and hypnotics. In multivariable analysis, factors associated with deprescribing of at least 1 drug prior to death included greater functional impairment (severe, adjusted odds ratio [aOR], 1.48; 95% CI, 1.39-1.58; moderate, aOR, 1.11; 95% CI, 1.04-1.18), worse cognitive impairment (severe, aOR, 1.25; 95% CI, 1.23-1.28; moderate, aOR, 1.08; 95% CI, 1.05-1.11), and hospice enrollment for dementia (aOR, 1.22; 95% CI, 1.19-1.25) or for nondementia diagnosis (aOR, 1.29; 95% CI, 1.26-1.32) vs no hospice. CONCLUSIONS AND IMPLICATIONS: Increases in chronic disease medications such as anticoagulants in the year prior to death among NH decedents with dementia suggest that further work is needed to guide end-of-life prescribing.

来源:J Am Med Dir Assoc,查看原文。版权归原作者所有。

引用

  1. Bochanis A, Rumbut J, Alcusky M, et al. Trajectories of Medication Use Prior to Death in US Nursing Home Residents With Dementia. J Am Med Dir Assoc. 2026. PMID: 42391770. doi:10.1016/j.jamda.2026.106330

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。